Table of Contents Table of Contents
Previous Page  21 / 22 Next Page
Information
Show Menu
Previous Page 21 / 22 Next Page
Page Background

Page 68

O c t o b e r 1 5 - 1 6 , 2 0 1 8 | T o k y o , J a p a n

Obesity Congress 2018, Diabetes Congress 2018 & Vaccines Congress 2018

Biomedical Research

|

ISSN: 0976-1683

|

Volume 29

2

nd

WORLD OBESITY CONGRESS

2

nd

WORLD VACCINES AND IMMUNOLOGY CONGRESS

&

&

DIABETES AND ENDOCRINOLOGY

International Conference on

Joint Event on

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

alliedacademies.com

YEARS

Biomed Res 2018, Volume 29 | DOI: 10.4066/biomedicalresearch-C5-014

USING RADIATION TO TURN THE TUMOR INTO AN “

IN SITU

” VACCINE

FOR LUNG CANCER

James Welsh

University of Texas MD Anderson, USA

F

or the last 100 years radiation has been used solely for location control, but now with the advent of immunotherapy, we have

the potential to expand the benefit of radiation to systemic disease. Our laboratory has generated the model of PD1 resistant

to lung cancer and using this model we are testing several new immunotherapies to produce abscopal systemic responses in

combination with radiation. We have recently completed three trials with 100 patients each of testing the safety and efficacy of

combing immunotherapy with radiation for lung cancer. This talk will educate the audience about the biological rationale of using

immunotherapy with antigen release from radiation along with the most up to date data on where the field is at, along with new

approaches for the future.

jwelsh@mdanderson.org